Your browser doesn't support javascript.
loading
Fast and Quantitative T1ρ-weighted Dynamic Glucose Enhanced MRI.
Schuenke, Patrick; Paech, Daniel; Koehler, Christina; Windschuh, Johannes; Bachert, Peter; Ladd, Mark E; Schlemmer, Heinz-Peter; Radbruch, Alexander; Zaiss, Moritz.
Afiliação
  • Schuenke P; German Cancer Research Center (DKFZ), Division of Medical Physics in Radiology, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
  • Paech D; German Cancer Research Center (DKFZ), Division of Radiology, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
  • Koehler C; German Cancer Research Center (DKFZ), Division of Radiology, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
  • Windschuh J; German Cancer Research Center (DKFZ), Division of Medical Physics in Radiology, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
  • Bachert P; German Cancer Research Center (DKFZ), Division of Medical Physics in Radiology, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
  • Ladd ME; German Cancer Research Center (DKFZ), Division of Medical Physics in Radiology, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
  • Schlemmer HP; German Cancer Research Center (DKFZ), Division of Radiology, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
  • Radbruch A; German Cancer Research Center (DKFZ), Division of Radiology, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
  • Zaiss M; German Cancer Research Center (DKFZ), Division of Medical Physics in Radiology, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Sci Rep ; 7: 42093, 2017 02 07.
Article em En | MEDLINE | ID: mdl-28169369
ABSTRACT
Common medical imaging techniques usually employ contrast agents that are chemically labeled, e.g. with radioisotopes in the case of PET, iodine in the case of CT or paramagnetic metals in the case of MRI to visualize the heterogeneity of the tumor microenvironment. Recently, it was shown that natural unlabeled D-glucose can be used as a nontoxic biodegradable contrast agent in Chemical Exchange sensitive Spin-Lock (CESL) magnetic resonance imaging (MRI) to detect the glucose uptake and potentially the metabolism of tumors. As an important step to fulfill the clinical needs for practicability, reproducibility and imaging speed we present here a robust and quantitative T1ρ-weighted technique for dynamic glucose enhanced MRI (DGE-MRI) with a temporal resolution of less than 7 seconds. Applied to a brain tumor patient, the new technique provided a distinct DGE contrast between tumor and healthy brain tissue and showed the detailed dynamics of the glucose enhancement after intravenous injection. Development of this fast and quantitative DGE-MRI technique allows for a more detailed analysis of DGE correlations in the future and potentially enables non-invasive diagnosis, staging and monitoring of tumor response to therapy.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Neoplasias Encefálicas / Imageamento por Ressonância Magnética / Aumento da Imagem / Glioblastoma / Meios de Contraste / Glucose Limite: Aged / Humans / Male Idioma: En Revista: Sci Rep Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Neoplasias Encefálicas / Imageamento por Ressonância Magnética / Aumento da Imagem / Glioblastoma / Meios de Contraste / Glucose Limite: Aged / Humans / Male Idioma: En Revista: Sci Rep Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha